Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ropivacaine concentration comparison for posterior quadratus lumborum block after laparoscopic hernia repair
ChiCTR2000031690Phase 4Not yet recruiting
- Sponsor
- Department of Anesthesiology, the Second Hospital of Shandong University
- Start
- Apr 2020
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of ropivacaine in inguinal hernia (2 arms), sponsored by Department of Anesthesiology, the Second Hospital of Shandong University. Primary endpoints: Total opioid consumption and Postoperative NRSS score. Planned start Apr 2020; status: not yet recruiting.
02
Drugs
ropivacaine
03
Conditions
inguinal hernia
Beyond the preview
Go deeper on ChiCTR2000031690.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2000031690.